SCHEMBL22021904

SCHEMBL22021904

BN1Cc2ccnnc2C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17753586 0.66 — —
SCHEMBL20128636 0.66 MAPT (0.39) —
SCHEMBL14570999 0.56 TRIM24 (0.33) —
SCHEMBL28513579 0.55 GSK3A (0.40) —
SCHEMBL29043805 0.54 — —
SCHEMBL4438848 0.54 — —
SCHEMBL9674642 0.54 METAP2 (0.47) —
SCHEMBL12339195 0.54 BMPR1B (0.36) —
SCHEMBL678602 0.53 — —
SCHEMBL4538791 0.53 S100A4 (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200157078-A1 NOVEL COMPOUNDS HAVING ESTROGEN RECEPTOR ALPHA DEGRADATION ACTIVITY AND USES THEREOF ACCUTAR BIOTECHNOLOGY INC. (US) 2020-05-21 — — US disclosed
Send feedback